An Oncogene-Induced DNA Damage Model for Cancer Development
Top Cited Papers
- 7 March 2008
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 319 (5868), 1352-1355
- https://doi.org/10.1126/science.1140735
Abstract
Of all types of DNA damage, DNA double-strand breaks (DSBs) pose the greatest challenge to cells. One might have, therefore, anticipated that a sizable number of DNA DSBs would be incompatible with cell proliferation. Yet recent experimental findings suggest that, in both precancerous lesions and cancers, activated oncogenes induce stalling and collapse of DNA replication forks, which in turn leads to formation of DNA DSBs. This continuous formation of DNA DSBs may contribute to the genomic instability that characterizes the vast majority of human cancers. In addition, in precancerous lesions, these DNA DSBs activate p53, which, by inducing apoptosis or senescence, raises a barrier to tumor progression. Breach of this barrier by various mechanisms, most notably by p53 mutations, that impair the DNA damage response pathway allows cancers to develop. Thus, oncogene-induced DNA damage may explain two key features of cancer: genomic instability and the high frequency of p53 mutations.Keywords
This publication has 28 references indexed in Scilit:
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Efficiency of carcinogenesis with and without a mutator mutationProceedings of the National Academy of Sciences, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesisOncogene, 2003
- 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancerNature Cell Biology, 2002
- The Hallmarks of CancerCell, 2000
- p53, guardian of the genomeNature, 1992